Annual report [Section 13 and 15(d), not S-K Item 405]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share The following securities were not included diluted shares outstanding because the effect would be anti-dilutive.

 

 

Years Ended December 31,

 

 

2024

 

 

2023

 

Stock options

 

 

5,287,284

 

 

 

3,223,881

 

Warrants

 

 

4,625,000

 

 

 

4,732,391

 

Convertible notes

 

 

176,222,145

 

 

 

116,568,908

 

Total anti-dilutive instrument

 

 

186,134,429

 

 

 

124,525,180